Use of GM-CSF in children after high-dose chemotherapy
Open Access
- 1 January 1992
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 20 (S1) , 26-30
- https://doi.org/10.1002/mpo.2950200707
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Growth factors and cancer chemotherapyThe Lancet, 1991
- A phase I/II trial of recombinant granulocyte-macrophage colony- stimulating factor for children with aplastic anemiaBlood, 1990
- Hematopoietic growth factors and high-dose chemotherapy: will grams succeed where milligrams fail?Journal of Clinical Oncology, 1990
- Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1990
- Escalated Therapy for Refractory Urothelial Tumors: Methotrexate- Vinblastine-Doxorubicin- Cisplatin Plus Unglycosylated Recombinant Human Granulocyte-macrophage Colony-Stimulating FactorJNCI Journal of the National Cancer Institute, 1990
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988